NasdaqCM - Nasdaq Real Time Price USD

Allarity Therapeutics, Inc. (ALLR)

1.0250
-0.0150
(-1.44%)
As of 11:45:45 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
16,334
17,538
17,129
16,892
26,556
Operating Income
-16,334
-17,538
-17,129
-16,892
-26,556
Net Non Operating Interest Income Expense
147
-120
-476
-193
-1,987
Other Income Expense
-7,594
-7,238
5,787
-494
2,028
Pretax Income
-23,781
-24,896
-11,818
-17,579
-26,515
Tax Provision
-377
-381
83
-1,521
133
Net Income Common Stockholders
-24,006
-25,154
-20,416
-21,051
-26,648
Diluted NI Available to Com Stockholders
-24,006
-25,154
-20,416
-21,051
-26,648
Basic EPS
648.26
-15.65
-6.03k
-31.80k
-79.07k
Diluted EPS
648.26
-15.65
-6.03k
-31.80k
-79.07k
Basic Average Shares
4,392.2590
1,606.9890
3.3850
0.6620
0.3370
Diluted Average Shares
4,392.2590
1,606.9890
3.3850
0.6620
0.3370
Total Operating Income as Reported
-26,037
-27,241
-17,129
-34,463
-26,556
Total Expenses
16,334
17,538
17,129
16,892
26,556
Net Income from Continuing & Discontinued Operation
-23,404
-24,515
-11,901
-16,058
-26,648
Normalized Income
-15,930.3876
-17,387.7679
-16,939.6200
-15,606.7427
-28,474.4600
Interest Income
755
533
22
30
0
Interest Expense
608
653
498
223
640
Net Interest Income
147
-120
-476
-193
-1,987
EBIT
-23,173
-24,243
-11,320
-17,356
-25,875
EBITDA
-23,155
-24,234
-11,283
-17,296
-25,769
Reconciled Depreciation
18
9
37
60
106
Net Income from Continuing Operation Net Minority Interest
-23,404
-24,515
-11,901
-16,058
-26,648
Total Unusual Items Excluding Goodwill
-7,594
-7,238
6,378
-494
2,502
Total Unusual Items
-7,594
-7,238
6,378
-494
2,502
Normalized EBITDA
-15,561
-16,996
-17,661
-16,802
-28,271
Tax Rate for Calcs
0
0
0.0002
0.0001
0.0003
Tax Effect of Unusual Items
-120.3876
-110.7679
1,339.3800
-42.7427
675.5400
12/31/2021 - 12/21/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HEPA Hepion Pharmaceuticals, Inc.
0.1106
+0.27%
 
TNFA TNF Pharmaceuticals, Inc.
0.1935
+2.42%
 
PHIO Phio Pharmaceuticals Corp.
1.7801
-3.26%
 
TVGN Tevogen Bio Holdings Inc.
1.1200
-0.88%
 
AEON AEON Biopharma, Inc.
0.4961
-0.78%
 
GNPX Genprex, Inc.
0.2558
+3.48%
 
PBM Psyence Biomedical Ltd.
5.70
+9.52%
 
ADTX Aditxt, Inc.
1.6801
+1.20%
 
KTTA Pasithea Therapeutics Corp.
0.9240
-3.35%
 
ONCO Onconetix, Inc.
0.0820
-3.19%